Prospective single-arm multicentre study of inverted T-tripedicle breast reduction in the treatment of physiologic moderate to severe breast hypertrophy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046596

Enrollment

Unknown

Registered

2021-05-22

Start date

2021-05-22

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast

Interventions

inverted T-tripedicle breast reduction group:N/A

Eligibility

Sex/Gender

Male

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Physiologically large breasts, unilateral removal of glands is estimated to be greater than 500g; 2. The patient has a strong desire for breast reduction, agrees to participate in this study, and is able and willing to sign an informed consent form; 3. Agree to follow up after surgery.

Exclusion criteria

Exclusion criteria: 1. A satisfactory breast shape cannot be achieved through surgery, and the breast has a malignant tumor; 2. Merge other serious diseases.

Design outcomes

Primary

Measure	Time frame
cosmetic effect;The safety of inverted T three - pedicle method of physiologic giant breast reduction;Symptoms were relieved after the physiologic mammary shrinkage spell;	—

Secondary

Measure	Time frame
Physiological giant breast shrink breast inverted T triple spell post social psychology;	—

Countries

China

Contacts

Public ContactDu Zhenggui

West China Hospital of Sichuan University

docduzg@163.com+86 13880768222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026